Targeted screening of SiRNA directed HBV polymerase gene for effective inhibition of HBV expression
- PMID: 18563320
- DOI: 10.1007/s11596-008-0308-1
Targeted screening of SiRNA directed HBV polymerase gene for effective inhibition of HBV expression
Abstract
In order to screen potential mRNA locations of P gene in which targeting siRNAs can effectively inhibit HBV expression, 5 recombinant plasmids containing 4 targeting-specific siRNA fragments and a control were prepared and transfected into 2.2.15 cells respectively. The expression levels of HBx mRNA, HBs mRNA and HBc mRNA were detected by RT-PCR. The concentrations of the hepatitis B virus antigens, including HBsAg and HBeAg harvested from the culture supernatant of transfected 2.2.15 cells, were measured by ELISA. X protein was tested by Western blot. The results showed that four siRNAs against distinct mRNA locations of HBV polymerase gene had different inhibitory effects on their targeted mRNA. The plasmid-derived psiRNA1 and psiRNA2 could effectively inhibit the transcription and translation of HBs gene, whereas the inhibitory efficiency of psiRNA3, psiRNA4 for HBe gene was much higher than that of psiRNA1 and psiRNA2. In comparison to the rest of psiRNAs in this study, psiRNA4 was the most effective to suppress the transcription and translation of HBx. It is suggested that siRNA can be considered as a powerful therapeutic agent for reducing HBV expression. The siRNAs against HBV polymerase are effective largely depending on the location of targeted sites. To enhance inhibitory efficiency, hunting for high effective target in polymerase gene is necessary and feasible.
Similar articles
-
Establishment of a screening system for selection of siRNA target sites directed against hepatitis B virus surface gene.Acta Biochim Biophys Sin (Shanghai). 2005 May;37(5):310-6. doi: 10.1111/j.1745-7270.2005.00049.x. Acta Biochim Biophys Sin (Shanghai). 2005. PMID: 15880259
-
[Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study].Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3079-83. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16324412 Chinese.
-
Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):828-832. doi: 10.1007/s11596-017-1810-0. Epub 2017 Dec 21. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29270739
-
siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection.J Drug Target. 2008 Feb;16(2):140-8. doi: 10.1080/10611860701878750. J Drug Target. 2008. PMID: 18274934 Free PMC article.
-
[PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].Zhonghua Yi Xue Za Zhi. 2012 Mar 20;92(11):768-72. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22781359 Chinese.
Cited by
-
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):309-12. doi: 10.1007/s11596-009-0309-8. Epub 2009 Jun 10. J Huazhong Univ Sci Technolog Med Sci. 2009. PMID: 19513612
-
Development and application of ribonucleic acid therapy strategies against COVID-19.Int J Biol Sci. 2022 Aug 1;18(13):5070-5085. doi: 10.7150/ijbs.72706. eCollection 2022. Int J Biol Sci. 2022. PMID: 35982905 Free PMC article. Review.
-
PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication.Front Immunol. 2022 Apr 29;13:856463. doi: 10.3389/fimmu.2022.856463. eCollection 2022. Front Immunol. 2022. PMID: 35572586 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical